Cargando…

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation

BACKGROUND: Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing hormone antagonist (GnRH-ant) protocol. For emergency fertility preservation, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Haipeng, Itaya, Yukiko, Samejima, Kouki, Ichinose, Shunichiro, Narita, Tatsuya, Matsunaga, Shigetaka, Saitoh, Masahiro, Takai, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725433/ https://www.ncbi.nlm.nih.gov/pubmed/34983605 http://dx.doi.org/10.1186/s13048-021-00935-5

Ejemplares similares

Late-onset ovarian hyperstimulation syndrome developing during ovarian stimulation in an ectopic pregnancy: a case report
por: Huang, Haipeng, et al.
Publicado: (2020)

Severe hemoperitoneum resulting from restart of letrozole after oocyte retrieval procedure: a case report
por: Huang, Haipeng, et al.
Publicado: (2021)

Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study
por: Filippi, Francesca, et al.
Publicado: (2023)

How could we suspect life‐threatening perinatal group A streptococcal infection?
por: Arai, Tomohiro, et al.
Publicado: (2020)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study
por: de Oliveira, Renato, et al.
Publicado: (2021)

Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
por: Wu, Shuxie, et al.
Publicado: (2023)

Body Mass Index Showed No Impact on the Outcome of In Vitro Fertilization in Progestin-Primed Ovarian Stimulation Protocol
por: Yang, Zhe, et al.
Publicado: (2021)

Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
por: Yang, Ai-Min, et al.
Publicado: (2022)

Editorial: Recent advances in progestin-primed ovarian stimulation
por: Chen, Qiuju
Publicado: (2022)

Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
por: Falcone, Francesca, et al.
Publicado: (2017)

Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer
por: Roh, Hyun Jin, et al.
Publicado: (2021)

Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2023)

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
por: Baek, Ji Sun, et al.
Publicado: (2016)

Fibrinogen for the management of critical obstetric hemorrhage
por: Matsunaga, Shigetaka, et al.
Publicado: (2018)

Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis
por: Yang, Liu, et al.
Publicado: (2023)

Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
por: Ye, Hongjuan, et al.
Publicado: (2018)

Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study
por: Lin, Yue, et al.
Publicado: (2021)

Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study
por: Huang, Jialyu, et al.
Publicado: (2019)

Placental abruption possibly due to parvovirus B19 infection
por: Kawabe, Ayaka, et al.
Publicado: (2016)

Random‐start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer
por: Nakasuji, Takashi, et al.
Publicado: (2019)

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
por: Shibasaki, Sena, et al.
Publicado: (2023)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
por: Liang, Zhou, et al.
Publicado: (2020)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
por: Zhang, Junwei, et al.
Publicado: (2021)

Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol
por: Li, Danjun, et al.
Publicado: (2022)

A delayed ovulation of progestin-primed ovarian stimulation (PPOS) by downregulating the LHCGR/PGR pathway
por: Xie, Yating, et al.
Publicado: (2023)

Risk factors for neonatal bronchopulmonary dysplasia in extremely preterm premature rupture of membranes: a retrospective study
por: Nakamura, Eishin, et al.
Publicado: (2020)

Fibrinogen may aid in the early differentiation between amniotic fluid embolism and postpartum haemorrhage: a retrospective chart review
por: Matsunaga, Shigetaka, et al.
Publicado: (2021)

Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina
por: Ishida, Hiroaki, et al.
Publicado: (2015)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study
por: Wang, Ningling, et al.
Publicado: (2018)

Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
por: Pai, Angel Hsin-Yu, et al.
Publicado: (2023)

Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures
por: Shen, Xi, et al.
Publicado: (2020)

Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First In Vitro Fertilization Cycle: A Retrospective Cohort Study
por: Tu, Xiaoyu, et al.
Publicado: (2022)

Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report
por: Honda, Michiko, et al.
Publicado: (2014)

Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial
por: Checa, Miguel A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oeks5g26nm1smso45v6oeq5u7d